Top Healthcare Stocks are CYCC, SQNM, DXCM

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) climbed up 4.27% to $2.68 on a massive volume of 2.68 million shares. The stock has a 52-week range of $0.25-$4.08. Cyclacel Pharmaceuticals, Inc. (Cyclacel) is a development-stage biopharmaceutical company engaged in the discovery, development and commercialization of mechanism-targeted drugs to treat human cancers and other serious disorders. The Company markets, directly in the United States, Xclair Cream for radiation dermatitis, and Numoisyn Liquid and Numoisyn Lozenges for xerostomia through its wholly owned subsidiary, ALIGN Pharmaceuticals, LLC (ALIGN).

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Sequenom, Inc. (NASDAQ:SQNM) rallied 5.06% to $4.36 on a massive volume of 2.13 million shares. The stock has a 52-week range of $2.55-$25.99. The company announced the entry of a settlement agreement which will resolve the consolidated securities class action lawsuits, In re Sequenom, Inc. Securities Litigation, Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay $14 million, which will be funded by insurance proceeds. Additionally the Company has agreed to issue to the plaintiffs' class a number of shares of Sequenom common stock. These shares shall constitute 9.95% of the total shares then outstanding, subject to certain limitations. The Company has also agreed to adopt or continue its implementation of changes and additions to certain corporate governance policies, protocols and practices.  

DexCom, Inc. (NASDAQ:DXCM) surged 6.62% to $9.83 with a massive volume of 1.01 million shares. The stock today also touched a new 52 week high at $9.89. The company announced the sale of 3.5 million shares of its common stock pursuant to an underwriting agreement with Canaccord Adams acting as the sole bookrunner. The last reported sale price of our common stock as reported by the Nasdaq Global Market on January 14, 2010 was $9.22 per share. The Company expects to use the net proceeds from the sale of the shares for working capital and general corporate purposes. Closing of the offering is expected to occur on or about January 21, 2010, subject to customary closing conditions. In addition, the Company has granted the underwriters a 30 day option to purchase up to an additional 525,000 shares of common stock to cover over allotments, if any.    

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap penny stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.